Fleseriu, Maria http://orcid.org/0000-0001-9284-6289
Buchfelder, Michael http://orcid.org/0000-0002-1955-4957
Cetas, Justin S. http://orcid.org/0000-0001-6711-035X
Fazeli, Pouneh K. http://orcid.org/0000-0003-1731-2927
Mallea-Gil, Susana M. http://orcid.org/0000-0002-3654-9877
Gurnell, Mark http://orcid.org/0000-0001-5745-6832
McCormack, Ann http://orcid.org/0000-0002-2859-5566
Pineyro, Maria M. http://orcid.org/0000-0003-2083-7839
Syro, Luis V. http://orcid.org/0000-0003-4154-6547
Tritos, Nicholas A. http://orcid.org/0000-0001-8867-607X
Marcus, Hani J. http://orcid.org/0000-0001-8000-392X
Article History
First Online: 18 June 2020
Compliance with ethical standards
:
: MF has received research support to OHSU as principal investigator from Chiasma, Crinetics, Ionis, Novartis, Strongbridge and has received occasional scientific consulting from Chiasma, Crinetics, Ionis, Novo Nordisk, Novartis, Pfizer, Strongbridge. MB, JSC, PKF, SMM-G, MG, AM, MMP, LVS declares that they have no conflict of interest. NAT has received institution-directed research support from Ipsen and Novartis and has received occasional consulting fees from Novo Nordisk and Strongbridge. HJM is supported by the Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS) and the NIHR BRC Neuro-oncology
: This article does not contain any studies with human subjects or animals performed by the authors.